Structure Therapeutics Inc. American Depositary Shares (GPCR) Stock Price
GPCRStock
$49.92+149.92%52W
Market Cap$3.56B
P/E—
PEG Ratio—
Div yield—
Beta-1.67
GPCR Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-39.55%
Price vs S&P 500 (4W)-0.71%
VGM Score62.92
GPCR Earnings Surprise History
Q2 25-0.36est. -0.28
Q3 25-0.37est. -0.37
Q4 250.20est. -0.37
Q1 26-0.35est. -0.31
Q2 26-0.49est. -0.38
GPCR Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.25
4.25
4.25
4.26
Industry Peers — Pharmaceuticals(571)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
GPCRStructure Therapeutics Inc. American Depositary Shares | — | — | B | $49.92 |
| LLYEli Lilly & Co. | D | B | B | $1233.66 |
| JNJJohnson & Johnson | D | C | B | $273.14 |
| ABBVABBVIE INC. | D | C | B | $265.79 |
| MRKMerck & Co., Inc. | D | C | A | $156.45 |
| NVSNovartis AG | C | C | C | $159.98 |
| AZNAstraZeneca PLC | C | B | C | $169.66 |
| NVONovo-Nordisk A/S | B | C | C | $48.66 |
| ABTAbbott Laboratories | C | C | B | $116.13 |
| PFEPfizer Inc. | C | D | C | $28.57 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $552.85 |
About Structure Therapeutics Inc. American Depositary Shares
Structure Therapeutics is a clinical-stage biopharmaceutical company developing oral small-molecule therapeutics targeting G-protein coupled receptors (GPCRs) for chronic diseases with unmet medical needs. The company's differentiated platform integrates structure-based drug discovery with computational chemistry expertise to advance its pipeline of potential medicines.